Progyny, Inc. (PGNY)
| Market Cap | n/a+37.8% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,261,578 |
| Open | n/a |
| Previous Close | 25.91 |
| Day's Range | 25.81 - 28.32 |
| 52-Week Range | 16.10 - 33.06 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$PGNY stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of PGNY by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jul 30, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jul 30, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jul 29, 2020 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jun 30, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jun 30, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jun 29, 2020 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jun 1, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jun 1, 2020 |
Recently reported changes in PGNY holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PGNY's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PGNY Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PGNY Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Fertility benefits services revenue | $230.21M | 65.68% |
| Pharmacy benefits services revenue | $120.30M | 34.32% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PGNY patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PGNY from public contracts
Source: USAspending.gov
PGNY Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PGNY’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score